Affiliation:
1. School of Chemistry and Life Science, Anshan Normal University, Anshan, Liaoning, China
Abstract
1,3,5-Triazine and azole can interact with various therapeutic targets, and their derivatives
possess promising in vitro and in vivo anticancer activity. Hybrid molecules have the potential to enhance
efficiency, overcome drug resistance and reduce side effects, and many hybrid molecules are under
different phases of clinical trials, so hybridization of 1,3,5-triazine with azole may provide valuable
therapeutic intervention for the treatment of cancer. Substantial efforts have been made to develop
azole-containing 1,3,5-triazine hybrids as novel anticancer agents, and some of them exhibited excellent
activity. This review emphasizes azole-containing 1,3,5-triazine hybrids with potential anticancer activity,
and the structure-activity relationships as well as the mechanisms of action are also discussed to
provide comprehensive and target-oriented information for the development of this kind of anticancer
drugs.
Funder
Foundation of Liaoning Educational Department
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel uracil derivatives as anti-cancer agents: Design, synthesis, biological evaluation and computational studies;Journal of Molecular Structure;2024-04
2. A concise review on anti-breast cancer effectiveness of s-triazines through EGFR kinase inhibition;Medicinal Chemistry Research;2023-12-21
3. Diverse Synthetic Approaches and Biological Activities of Lucrative Pyrimidine-
triazine Hybrid Derivatives: A Review;Current Organic Synthesis;2023-11
4. Hybrid PABA‐glutamic acid conjugated 1,3,5‐triazine derivatives: Design, synthesis, and antimalarial activity screening targeting Plasmodium falciparum dihydro folate reductase enzyme;Chemical Biology & Drug Design;2023-10-02
5. Azole-methyl-3-(4-phenoxyphenyl) quinazolin-4(3H) ones, novel quinazoline-azole hybrid scaffolds, as new potent anticancer agents: Design, synthesis, biological evaluation, molecular dynamic simulation and theoretical approach;Tetrahedron;2023-10